$5.50
-0.24[-4.18%]
At close: Apr 24
$5.50
0[0.00%]
After Hours: 4:22PM EDT
Travere Therapeutics
(NASDAQ:TVTX)Travere Therapeutics Stock (NASDAQ:TVTX), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/09/2023 | TVTX | Travere Therapeutics | FY | 2022 | — | — | — | $212.00M | $212.00M | $212.08M | Get Alert |
| 01/10/2022 | TVTX | Travere Therapeutics | FY | 2021 | — | — | — | $227.00M | $227.00M | $227.25M | Get Alert |
| 01/11/2021 | TVTX | Travere Therapeutics | Q4 | 2020 | — | — | — | $51.00M | $51.00M | $51.33M | Get Alert |
| 01/11/2021 | TVTX | Travere Therapeutics | FY | 2020 | — | — | — | $199.00M | $199.00M | $198.61M | Get Alert |
FAQ
What is the most recent guidance for Travere Therapeutics (TVTX)?
There have been no specific sales or earnings guidance reported for Travere Therapeutics in recent months.
Browse guidance and forecast on all stocks.